Binary Outcome Non-Inferiority Trial
A Binary Outcome Non-Inferiority Trial is a clinical trial method that aims to prove that a new treatment is not inferior to an established treatment with regard to a binary outcome. Such outcomes can be, for example, “success” vs. “failure” or “survival” vs. “death”.
Novustat is your experienced partner and advises you on all aspects of statistics, from data analysis to the interpretation of results, and helps you to gain maximum insight from your data sets. Contact us without obligation for further information!
Goal and concept
The goal of a non-inferiority trial is to demonstrate that the new treatment has no clinically relevant disadvantage compared to the existing treatment. In contrast to superiority trials, which aim to demonstrate a better outcome, or equivalence trials, which are designed to prove equivalence, a non-inferiority trial defines an acceptable level of inferior performance, known as the non-inferiority margin.
Free online calculators for calculating sample size
Use our online calculator to quickly and easily calculate the required sample size for your non-inferiority study.
Calculating the sample size
Calculating the sample size is essential to ensure that the study has sufficient statistical power to demonstrate non-inferiority. A predefined difference (the non-inferiority margin) is used to define the clinically acceptable difference between the groups. Our specialized calculator helps you determine the optimal sample size based on these parameters.
Application and requirements
An example of a binary outcome non-inferiority trial would be the comparison of a new generic drug with a branded drug for the treatment of a disease where the primary outcome is “success” vs. “failure”. Setting the non-inferiority threshold at 10% means that the cure rate of the new drug must not be more than 10% worse than that of the branded drug to be considered non-inferior.
Conducting such a trial requires a clear definition of the non-inferiority threshold as well as careful planning and analysis to avoid bias and ensure valid results.
Guidelines for calculating sample size for non-inferiority studies with binary outcomes
The calculation of the sample size is based on the expected success rate in both groups, the specified non-inferiority margin, and the statistical parameters of significance level and power.
Significance level (alpha)
The significance level, also known as alpha (α) , describes the risk of falsely detecting a difference between the groups when none exists. An alpha of 0.05 is usually used.
Power (1-Beta)
The power of a study (1-β) shows how likely it is to detect a real difference when it actually exists. In non-inferiority trials, a power of 80% to 90% is often aimed for to ensure reliable results.
Percentage success rate in both groups
The success rate (Ï€\pi) is the proportion of patients who achieve the desired result in both groups. In non-inferiority trials, it is assumed that the success rates of both groups are similar but not identical.
Non-inferiority limit (d)
The non-inferiority threshold (dd) defines the maximum acceptable difference between the success rates of the two groups at which the new treatment is still considered non-inferior. For example, a value of 10% (d = 10) could mean that a difference of up to 10% is considered acceptable.
Formula for calculation
The sample size is calculated using the following formula:
Here, π1 represents the success rate in the experimental group, π2 represents the success rate in the control group, and f(α, β) represents the Z-scores, which are determined by the significance level and the power. This formula ensures that the sample size calculation is accurate and yields meaningful results in your non-inferiority study.
Frequently asked questions
What is a binary outcome non-inferiority trial?
This trial examines whether a new treatment is no more than a predefined acceptable margin worse than the control for a binary outcome.
What is the non-inferiority margin?
It defines the maximum acceptable disadvantage of the new treatment compared with the established comparator.
When is this study design appropriate?
It is appropriate when a new treatment offers other advantages, such as lower costs, fewer side effects, or easier administration.
Which factors determine the sample size?
Expected success rates, the non-inferiority margin, significance level, and desired power determine the required sample size.
How does non-inferiority differ from equivalence?
Non-inferiority tests one-sided whether the new treatment is not meaningfully worse. Equivalence requires the difference to lie within both margins.
Plan non-inferiority trials with binary outcomes with confidence.
NOVUSTAT supports you from justifying the non-inferiority margin and planning sample size through statistical analysis and transparent interpretation of binary outcomes.
